BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/14/2025 10:33:15 AM | Browse: 185 | Download: 694
 |
Received |
|
2024-09-10 20:45 |
|
Peer-Review Started |
|
2024-09-10 20:45 |
|
First Decision by Editorial Office Director |
|
2024-10-28 07:57 |
|
Return for Revision |
|
2024-10-28 07:57 |
|
Revised |
|
2024-11-09 19:41 |
|
Publication Fee Transferred |
|
2024-11-12 16:21 |
|
Second Decision by Editor |
|
2024-12-12 02:40 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-12-12 06:59 |
|
Articles in Press |
|
2024-12-12 06:59 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-12-19 02:15 |
|
Publish the Manuscript Online |
|
2025-02-14 10:33 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Assessment of new pathological markers in early stage colon cancer: Insights and limitations
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Bulent Erdogan, Fatma Elif Usturalı Keskin, Erkan Özcan, Ahmet Küçükarda, Ali Kaan Güren, Osman Köstek, Bekir Muhammet Hacioglu and Hilmi Kodaz |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Hilmi Kodaz, Professor, Department of Medical Oncology, Acibadem Eskisehir Hospital, Hosnudiye District, Eskibaglar Street, No. 19 Tepebası, Eskisehir 26130, Türkiye. hilmikodaz@hotmail.com |
| Key Words |
Colon cancer; Early stage; Risk factors; New pathological markers; Tumor-stroma ratio; Tumor infiltrating lymphocytes; Crohn-like reaction; Desmoid reaction; Poorly differentiated clusters |
| Core Tip |
When their associations with the pathological marker in the risk group were evaluated, it was found that there was a significant correlation between the presence of poorly differentiated clusters (PDC) and the presence of PDC grade 3 and advanced T stage. This showed us that PDC is one of the markers to be used in cases where these risk factors are insufficient. |
| Publish Date |
2025-02-14 10:33 |
| Citation |
Erdogan B, Usturalı Keskin FE, Özcan E, Küçükarda A, Güren AK, Köstek O, Hacioglu BM, Kodaz H. Assessment of new pathological markers in early stage colon cancer: Insights and limitations. World J Gastrointest Oncol 2025; 17(3): 101325 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i3/101325.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i3.101325 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
